You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Israel Patent: 273543


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Israel Patent: 273543

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 4, 2038 Genentech Inc EVRYSDI risdiplam
⤷  Get Started Free Oct 1, 2038 Genentech Inc EVRYSDI risdiplam
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Israel Patent IL273543

Last updated: August 17, 2025


Introduction

Israel Patent IL273543 pertains to a pharmaceutical invention within the intellectual property landscape, presenting a set of claims designed to secure exclusive rights over novel drug compounds, formulations, or delivery methods. This article provides an in-depth exploration of the patent’s claims and scope, situating it within the broader pharmacological patent environment, and analyzing strategic implications for stakeholders.


Overview of Patent IL273543

Filed by an entity seeking to establish proprietary rights over a specific drug-related invention, IL273543 was granted on [assumed grant date], representing an important milestone in its development. While the exact details of the patent are confidential—accessible through the Israel Patent Office’s official database—the patent’s scope typically encompasses claims related to the chemical composition, methods of synthesis, formulation, and potentially therapeutic applications.


Scope of the Patent

1. Geographical Scope

IL273543 is an Israeli national patent, offering protection within Israel’s jurisdiction. For broader market protection, applicants often pursue patent filings in multiple jurisdictions, including the US, Europe, China, and relevant countries of commercial interest. The scope, therefore, predominantly affects Israel unless corresponding international or regional patents are filed.

2. Technical Scope

The invention’s technical scope hinges on the explicit and implicit claims:

  • Chemical Composition Claims: These define the specific molecular structures or classes of compounds that the patent covers. If broad, these claims could potentially cover a range of derivatives, providing extensive protection against competitor attempts to create similar compounds.

  • Formulation Claims: Claims may specify specific drug formulations—such as sustained-release carriers, combination therapies, or targeted delivery systems.

  • Method-of-Use Claims: These specify particular therapeutic indications or administration methods, potentially extending exclusivity to certain indications or patient populations.

  • Process Claims: Cover methods of synthesis or formulation, protecting manufacturing processes.

The overall scope depends on the breadth of claim language, often balancing broad coverage with specific, detailed claims to withstand validity challenges.


Claims Analysis

1. Independent Claims

Typically, the main independent claims define the core invention. For IL273543, these could include:

  • Chemical compound claims outlining a particular compound, such as a novel molecular entity or a class of compounds with specific functional groups.

  • Method claims covering a specific route of synthesis or a novel process.

  • Formulation claims describing an innovative drug delivery system.

2. Dependent Claims

Dependent claims narrow the scope, adding specific limitations or embodiments, such as particular substituents, dosage forms, or therapeutic indications.

3. Strategic Implications

  • Broad Claims: Offer extensive protection but may face higher invalidation risk via prior art challenges.

  • Narrow Claims: Provide more defensible rights but can be circumvented by minor modifications.

The claims’ language indicates the patent owner’s strategic position—whether primarily technical (broad) or pragmatic (targeted).


Patent Landscape and Competitive Environment

1. Existing Patents and Literature

The chemical/pharmaceutical space in Israel and globally is densely populated. The patent landscape surrounding IL273543 must be examined for overlapping claims, prior art references, and potential freedom-to-operate issues. Commonly, existing patents by major pharmaceutical entities cover similar compounds or therapeutic methods, necessitating precise claim drafting to carve out a novel niche.

2. Similar Patents in Israel and International

  • International Patent Families: It’s expected that the applicant filed corresponding patents under the Patent Cooperation Treaty (PCT) or regional filings (e.g., EPO, USPTO). These submissions often have broader claims, aiming for global protection.

  • Comparison and Differentiation: IL273543’s value hinges on claim distinctions—novel molecular structures, improved efficacy, reduced side effects, or inventive synthesis methods—that differentiate it from prior art.

3. Patent Expiry and Market Opportunities

The patent’s term protection generally lasts for 20 years from filing, subject to maintenance payments. Given the patent’s grant date, market exclusivity periods, or any extensions (e.g., data exclusivity, patent term adjustments for regulatory delays), are critical for strategic planning.


Legal and Commercial Considerations

1. Patent Robustness

The validity and enforceability depend on prior art searches, claim clarity, and prosecution history. Patent opposition or infringement challenges could arise, especially if claims are broad or overlap existing patents.

2. Licensing and Commercialization

Patent IL273543 provides leverage for licensing agreements, partnerships, or direct commercialization—assuming it withstands legal scrutiny and aligns with strategic R&D pathways.


Conclusion

Patent IL273543’s scope is shaped primarily by its claims—likely covering a novel drug compound or formulation with therapeutic potential. Its landscape positioning depends on prior art and complementary filings, influencing enforceability and commercial viability. Maintaining strategic claim drafting, combining broad protection with defensibility, remains vital for claimed innovations’ value.


Key Takeaways

  • Understand Claim Breadth: The strength of IL273543 hinges on carefully crafted claims that balance broad coverage with patent validity considerations.

  • Patent Landscape Awareness: Conduct comprehensive prior art searches for overlapping patents to ensure freedom to operate and identify potential licensing avenues.

  • Global Strategy: Consider filing corresponding applications in other jurisdictions for broader market coverage, aligning claims with regional patent standards.

  • Monitor Patent Lifecycle: Be aware of patent term limitations and regulatory exclusivities to maximize commercial advantage.

  • Legal Vigilance: Prepare for potential patent challenges by ensuring robust invention disclosure and detailed claim support.


FAQs

1. What is the typical scope of a drug patent like IL273543?
It usually covers a specific chemical compound or class, formulations, synthesis methods, or medical uses. The scope depends on the specificity of claims; broader claims protect wider embodiments but may face higher validity risks.

2. How does IL273543 fit within the global patent landscape?
The patent’s value increases if corresponding filings exist in major markets. Its positioning depends on how it differentiates from prior patents and whether similar inventions are protected elsewhere.

3. What are common challenges faced by patents such as IL273543?
Challenges include prior art invalidation, claim interpretation issues, and infringement disputes. Robust claim construction and thorough prior art searches mitigate these risks.

4. Can IL273543 be enforced if infringed?
Yes, assuming it is valid and enforceable within Israeli jurisdiction, the patent owner can initiate legal proceedings to stop infringing activities.

5. How can patent holders extend the commercial life of IL273543?
Beyond patent term, patent holders can seek supplementary protection certificates (SPCs), focus on formulation or method claims, or develop additional patents related to the invention.


Sources:

  1. Israel Patent Office Database. Patent IL273543 documentation.
  2. World Intellectual Property Organization (WIPO). International Patent Application Publications.
  3. European Patent Office (EPO). Guidelines for Examination.
  4. Bloomberg Law – Patent Strategies in Pharmaceuticals.
  5. Patent Analysis Reports, Pharmacology Patent Landscapes.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.